FIELD: chemistry.
SUBSTANCE: invention relates to a novel chemical compound - 1-(2-isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo [3,2-d]pyrimidin-4-one and pharmaceutically acceptable salts thereof, a pharmaceutical composition containing said compounds and use thereof. Disclosed compound has myeloperoxidase enzyme inhibiting properties.
EFFECT: compounds are especially useful in treating and preventing neuroinflammatory disorders such as Parkinson's disease, cardiovascular disorders and respiratory disorders.
3 cl, 1 tbl, 33 ex
Title | Year | Author | Number |
---|---|---|---|
NEW PYRROLO[3,2-d]PYRIMIDIN-4-ONE DERIVATIVES AND USING THEM IN THERAPY | 2005 |
|
RU2577858C2 |
DERIVATIVES OF THIOXANTHINE AS MYELOPEROXIDASE INHIBITORS | 2003 |
|
RU2323219C2 |
HYDROXYPURINE COMPOUNDS AND USE THEREOF | 2016 |
|
RU2685417C1 |
PYRROLOPYRAZINE KINASE INHIBITORS | 2012 |
|
RU2673064C2 |
INHIBITORS OF CDK | 2011 |
|
RU2621674C2 |
SUBSTITUTED COMPOUNDS OF THIOPHEN AND FURAN-CONDENSED AZOLOPYRIMIDIN-5-(6H)-OH | 2013 |
|
RU2659779C2 |
INFLUENZA VIRUS REPLICATION INHIBITORS, METHODS OF APPLICATION AND USING | 2016 |
|
RU2737190C2 |
PIPERIDINE DERIVATIVES | 2011 |
|
RU2554353C2 |
PHOSPHODIESTERASE TYPE 5 INHIBITOR RELEASING NITROGEN OXIDE | 2019 |
|
RU2785776C2 |
COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS | 2016 |
|
RU2717238C2 |
Authors
Dates
2011-01-20—Published
2005-12-05—Filed